The orphan nuclear receptors in cancer and diabetes

Harmit S Ranhotra1

  • 1Orphan Nuclear Receptors Laboratory, Department of Biochemistry, St. Edmund's College, Shillong, India. harmitran@gmail.com

Insights

Orphan nuclear receptors (ONRs) regulate gene expression and are crucial for metabolism and development. This review explores their role in modulating cancer and diabetes.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Genetics

Background:

  • Orphan nuclear receptors (ONRs) are a class of nuclear receptors (NRs) lacking identified endogenous ligands.
  • ONRs play critical roles in diverse physiological processes including metabolism, immunity, and development.
  • Dysregulation of ONRs is implicated in various human diseases.

Purpose of the Study:

  • To review the current understanding of the interplay between select ONRs and the patho-physiological conditions of cancer and diabetes.
  • To highlight the potential of ONRs as therapeutic targets for these diseases.

Main Methods:

  • Literature review of studies on orphan nuclear receptors.
  • Analysis of research linking ONRs to cancer and diabetes pathogenesis.
  • Synthesis of current findings on ONR function in disease.

Main Results:

  • Several ONRs have been identified to modulate key pathways involved in cancer development and progression.
  • Specific ONRs play significant roles in regulating glucose metabolism and insulin signaling, relevant to diabetes.
  • The interplay between ONRs and these diseases is complex, involving intricate regulatory networks.

Conclusions:

  • Orphan nuclear receptors are critical regulators with significant implications in cancer and diabetes.
  • Targeting specific ONRs holds promise for novel therapeutic strategies for these prevalent diseases.
  • Further research is warranted to fully elucidate the mechanisms underlying ONR involvement in patho-physiology.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...